HCM Marketplace

WEBCAST ON CD

Sponsored by Pharma-Sponsored CME Online Training
presented on MARCH 14, 2007

Afraid that proving a positive outcome from your CME efforts may send unwarranted red flags to regulatory officials?

You are not alone. Research shows that many pharma companies are hesitant to document successful CME ROI in fear that regulators may view the outcome as suspect. Watch and listen to this Webcast to hear a robust discussion on current best practices and trends in the industry. Our CME experts provide benchmarking data and intuitive dialogue on compliant and effective measurement strategies.

Listen to Elio Evangelista, senior analyst at Cutting Edge, as he reveals exclusive data from the recent Continuing Medical Education study and listen to our panel of experts, Barbara A. Fuchs, MSA, Associate Director in Professional Education Support, Wyeth Pharmaceuticals, Anthony M. Iacono, founder of Access Medical Network, Inc., and Stephen J. McConnell, Esq., Dechert LLP, as they comment on the findings, including tips on what is measurable and supportable, issues around RFPs and soft outcomes, and how to effectively plan a budget throughout the year.

AGENDA

I. Building Effective Firewalls
A. Top challenges faced by participating pharma CME programs
B. CME departments reporting relationships
C. Organizational structure before and after compliance guidelines
D. Post-OIG CME grant processing model
E. Panelists reactions and best practice tips

II. CME Funding
A. Budget structure: CME alignment
B. CME spending per event at surveyed companies
C. CME budget projections for 2007
D. Comparing number of CME events sponsored in 2005, 2006, 2007
E. Panelists reactions and best practice tips

III. Performance Measurement and ROI
A. Percentage of pharma companies that track CME ROI
B. Companies’ self-assessments of CME events’ ROI
C. CME Soft Goal performance measurement process
D. Panelists reactions and best practice tips

Q&A

LEARNING OBJECTIVES

• Obtain exclusive data from Cutting Edge CME benchmarking survey
• Learn ways to document CME performance without raising unnecessary regulatory red flags
• Gain best practice methods for CME budgeting for 2007

MEET OUR SPEAKERS

Elio Evangelista, is Senior Research Analyst of Cutting Edge Information where his background includes a primary concentration on brand and commercialization support activities, such as thought leader management, market research and competitive intelligence. As author of several major studies on critical decision-support functions, Mr. Evangelista presents Cutting Edge Information's findings on these topics to companies within the pharmaceutical industry. Aside from leading research studies and consulting projects, Mr. Evangelista has also helped develop Cutting Edge Information's Marketing Assessment program. His media appearances include BusinessWeek, Pharmaceutical Executive, PharmaVoice, and SCIP online.

Anthony M. Iacono is founder of Access Medical Network, Inc., a company specializing in aligning the continuing professional development needs of healthcare providers to the funding strategies of independent education supporters in order to maximize the quality, and improve the positive impact, of education initiatives on patient outcomes. Prior to Access Medical Network he held the position of Assistant Vice President, Marketing and Sales Operations, Wyeth Pharmaceuticals. In that capacity he played a key role in Medical Education and grant funding activities as well as holding a leadership role on related compliance issues as chair of the Promotional Guidelines Committee for the company.

Barbara A. Fuchs, MSA, is a Director in Professional Education Support at Wyeth Pharmaceuticals. She has many years of experience as a healthcare professional, holding key clinical and administrative positions in healthcare organizations including managed care. Prior to joining Wyeth, she served as the Executive Director of a for-profit Continuing Medical Education company. This has given her a unique perspective on the regulations governing CME as well as the grant process.

Stephen J. McConnell, Esq., is a partner in the mass torts and product liability group at Dechert LLP in Philadelphia, PA. He has also handled securities litigation, complex commercial litigation, and white-collar criminal litigation. Mr. McConnell served as an Assistant United States Attorney in the Central District of California (Los Angeles), where he investigated and prosecuted criminal cases in the Major Frauds Section.

WHO SHOULD ATTEND?

Pharmaceutical manufacturers in these divisions and focus areas:

• Clinical and Scientific Affairs
• Corporate Compliance
• Drug Safety
• Legal and Regulatory Affairs
• Marketing Strategy
• Medical Affairs/Regulatory Affairs
• Medical Education Grants
• Product Management Team
• Promotional Regulatory Affairs
• Promotional Review and Compliance

Purchase a CD of the program and learn when you can. It's also a perfect training tool for new staff or as a refresher for veteran staff.

• Audioconferences

• Other Life Sciences Products